Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 177

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist

Open access
Ludwig, Barbara, Rotem, Avi, Schmid, Janine, Weir, Gordon C., Colton, Clark K., Brendel, Mathias D., Neufeld, Tova, Block, Norman L., Yavriyants, Karina, Steffen, Anja, Ludwig, Stefan, Chavakis, Triantafyllos, Reichel, Andreas, Azarov, Dimitri, Zimermann, Baruch, Maimon, Shiri, Balyura, Mariya, Rozenshtein, Tania, Shabtay, Noa, Vardi, Pnina, Bloch, Konstantin, de Vos, Paul, Schally, Andrew V., Bornstein, Stefan R., Barkai, Uriel·2012·Proceedings of the National Academy of Sciences

Abstract

Islet transplantation is a feasible therapeutic alternative for metabolically labile patients with type 1 diabetes. The primary therapeutic target is stable glycemic control and prevention of complications associated with diabetes by reconstitution of endogenous insulin secretion. However, critical shortage of donor organs, gradual loss in graft function over time, and chronic need for immunosuppression limit the indication for islet transplantation to a small group of patients. Here we present a promising approach to address these limitations by utilization of a macrochamber specially engineered for islet transplantation. The s.c. implantable device allows for controlled and adequate oxygen supply and provides immunological protection of donor islets against the host immune system. The minimally invasive implantable chamber normalized blood glucose in streptozotocin-induced diabetic rodents for up to 3 mo. Sufficient graft function depended on oxygen supply. Pretreatment with the growth hormone-releasing hormone (GHRH) agonist, JI-36, significantly enhanced graft function by improving glucose tolerance and increasing β-cell insulin reserve in rats thereby allowing for a reduction of the islet mass required for metabolic control. As a result of hypervascularization of the tissue surrounding the device, no relevant delay in insulin response to glucose changes has been observed. Consequently, this system opens up a fundamental strategy for therapy of diabetes and may provide a promising avenue for future approaches to xenotransplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1201868109

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 177

Metadata

Authors
Ludwig, B., Rotem, A., Schmid, J., Weir, G. C., Colton, C. K., Brendel, M. D., Neufeld, T., Block, N. L., Yavriyants, K., Steffen, A., Ludwig, S., Chavakis, T., Reichel, A., Azarov, D., Zimermann, B., Maimon, S., Balyura, M., Rozenshtein, T., Shabtay, N., Vardi, P., Bloch, K., de Vos, P., Schally, A. V., Bornstein, S. R., & Barkai, U.
Venue
Proceedings of the National Academy of Sciences
Published
2012-03-05
Volume
109
Issue
13
Pages
5022-5027
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2163175336
Cited by
177
References
2
FWCI
18.64
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. https://app.cochat.ai/papers/10.1073/pnas.1201868109
The paper
Ludwig, B., Rotem, A., Schmid, J., Weir, G. C., Colton, C. K., Brendel, M. D., Neufeld, T., Block, N. L., Yavriyants, K., Steffen, A., Ludwig, S., Chavakis, T., Reichel, A., Azarov, D., Zimermann, B., Maimon, S., Balyura, M., Rozenshtein, T., Shabtay, N., . . . Barkai, U. (2012). Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1201868109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.